Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their volatility can be an asset.

| More on:
A cannabis plant grows.

Source: Getty Images

Few bear markets in Canada have been as brutal as the one that the marijuana sector suffered through. From the giants of the industry to smaller players, almost all marijuana stocks experienced massive growth when the sentiment about the industry was highly positive, and legal marijuana was expected to be the next best thing.

But when it became clear that marijuana companies in Canada would have a long and arduous war with the black market products that still permeate a significant segment of the Canadian market, the sentiment began to change. It triggered a long and considerable slump, which caused many marijuana companies to lose up to 90% of their valuation over time.

However, hitting rock bottom has its perks. Many marijuana stocks experience a spike in performance even when something moderately good happens in the industry, and that’s what is happening with Canopy Growth (TSX:WEED) right now.

A fallen giant

Canopy Growth was one of the largest cannabis companies in the world at one time, and even though it’s still in the top 10 cannabis companies by market cap, it has fallen several steps. Several reasons exist, including a weak sector, government regulations, and the company’s own management and business model weaknesses.

One of the most significant internal weaknesses of the company is that, in the past, it has liberally used share dilution to raise the required cash. While this allowed the company to build its portfolio of products and facilities, that’s quite impressive, the long-term implications haven’t been in the company’s favour yet.

The stock has lost over 98.5% of its market valuation from its 2019 peak, when it traded upwards of $670 per share. Now, it’s barely hitting the double digits now. It was at low single digits a while back, but the news that the U.S. might decriminalize marijuana at a federal level triggered a strong bullish phase. The stock rose by about 200% in just two weeks but is already heading toward a correction phase.

The future

There is no doubt that the U.S. is heading toward federal decriminalization of marijuana. Two-dozen states have already legalized its recreational use, and commercial distribution is also permitted in most of these states. Still, the actual trigger, especially for producers in Canada (especially if they have a U.S. presence), would be the federal legalization of marijuana.

When that happens, buying Canopy Growth might result in significant short-term gains, but buying now may not be the best course of action. The stock may dip, and if you wait for the right time to buy, you can get an even more discounted price and capture a larger piece of growth than you would if you buy now.

Foolish takeaway

It’s important to note that most cannabis stocks in Canada might surge when the U.S. government legalizes cannabis, but for almost all of them, the growth will have two phases.

The initial sentiment-driven phase would push nearly all stocks up — some more; some less. Then, after a correction, there might be a second phase of growth for companies that have actually benefited from this legalization, as evidenced by their financials.  

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »